Approval · Notice of Compliance 37034 · 2026
IPG-EZETIMIBE: Notice of Compliance 37034
Issued March 4, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37034
- Date
- March 4, 2026
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site and/or manufacturer involving production of the drug substance
- Canadian reference product
- EZETROL
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-EZETIMIBE | Not yet assigned | — |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB